Phase II Trial of Trifluridine/Tipiracil (FTD/TPI (TAS-102)) in Biliary Tract Cancers
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2018
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Biliary cancer; Biliary tract disorders
- Focus Therapeutic Use
- 18 Oct 2018 Status changed from recruiting to suspended.
- 23 Oct 2017 Status changed from not yet recruiting to recruiting.
- 12 Oct 2017 Planned initiation date changed from 15 Sep 2017 to 15 Dec 2017.